首页> 美国卫生研究院文献>Microorganisms >Mechanisms of Linezolid Resistance Among Enterococci of Clinical Origin in Spain—Detection of optrA- and cfr(D)-Carrying E.faecalis
【2h】

Mechanisms of Linezolid Resistance Among Enterococci of Clinical Origin in Spain—Detection of optrA- and cfr(D)-Carrying E.faecalis

机译:西班牙检测临床原产能肠球菌抗性机制 - 检测OPTRA-和CFR(D) - rryinge.粪便

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mechanisms of linezolid resistance among 13 and 6 isolates, recovered from six Spanish hospitals during 2017–2018, were investigated. The presence of acquired linezolid resistance genes and mutations in 23S rDNA and in genes encoding for ribosomal proteins was analyzed by PCR and amplicon sequencing. Moreover, the susceptibility to 18 antimicrobial agents was investigated, and the respective molecular background was elucidated by PCR-amplicon sequencing and whole genome sequencing. The transferability of the linezolid resistance genes was evaluated by filter-mating experiments. The gene was detected in all 13 isolates; and one -positive isolate also carried the recently described (D) gene. Moreover, one isolate displayed the nucleotide mutation G2576T in the 23S rDNA. This mutation was also present in all six isolates. All linezolid-resistant enterococci showed a multiresistance phenotype and harbored several antimicrobial resistance genes, as well as many virulence determinants. The gene was located upstream of the gene in 12 of the isolates. Moreover, an (A)-like gene was located downstream of in two isolates recovered from the same hospital. The gene was transferable in all but one isolates, in all cases along with the gene. The (D) gene was not transferable. The presence of and mutations in the 23S rDNA are the main mechanisms of linezolid resistance among and , respectively. We report the first description of the (D) gene in . The presence of the and (D) genes in Spanish hospitals is a public health concern.
机译:研究了来自2017 - 2018年六家西班牙医院的13和6个分离株之间的线唑抗性的机制。通过PCR和扩增子测序分析了23S rDNA抗性基因和23s RDNA和编码核糖体蛋白基因中的突变的存在。此外,研究了对18种抗微生物剂的敏感性,并通过PCR - 扩增子测序和全基因组测序阐明了各种分子背景。通过过滤配合实验评价脱脂糖基因的可转移性。在所有13个分离物中检测到基因;并且一种阳性分离物也携带最近描述的(d)基因。此外,一种分离物在23s RDNA中显示核苷酸突变G2576T。这种突变也存在于所有六个分离物中。所有Lieboolid肠道肠道癌均显示多觉表型并患有几种抗微生物抗性基因,以及许多毒力决定因素。该基因位于分离株12中的基因的上游。此外,(a)的基因位于从同一医院回收的两种分离物的下游。在所有情况下,除了一个分离株外,基因在所有情况下都可以转移。 (d)基因不可转移。 23s rdNA中的存在和突变分别是抗肾上腺素抗性的主要机制。我们报告了(d)基因的第一个描述。西班牙医院的(d)基因的存在是公共卫生问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号